Comprehensive coverage

An implant will improve the chances of recovering from cancer and a first-of-its-kind antibody to treat chronic arthritis

Another cluster for the Biomed conference

An implant will improve the chance of recovering from cancer.

A biodegradable polymer implant of application and myrtle will focus the radiation during radiation treatments of cancer patients and prevent the development of cancer metastases. The biodegradable implant, which emits harmless radioactive radiation, is inserted into the body in the area where a cancerous metastasis was removed and allows the doctor to focus the radiation in the following radiations. Thus it significantly improves the patient's quality of life. The implant is safe, does not irritate the tissues in which it resides, and is effective in preventing recurrent tumors. The technology is owned by Application and Hadassit.

First antibody of its kind for the treatment of chronic arthritis.

The Maimonidex company, from Red Biomed, has developed an antibody, the first of its kind, to prevent the development of joint inflammation. Chronic arthritis currently affects about 2% of the population in Western countries and being a chronic disease, it requires long and expensive treatment. With the help of the innovative antibody, the patient will overcome the disease without financial burden. Today there is no specific cure for chronic arthritis, the existing treatments are mainly at the level of the symptoms, and the new antibody will be the first to provide an answer to the disease itself.

In the picture: the palm of a patient with chronic arthritis, the response of the Mimonidex company, and the result. (Maimonidex hands fixed.jpg)

Testing device without full anesthesia and without opening/puncturing the abdominal cavity

The endoscope, developed by the Medigus company (Medigus device.jpg)

The Maedigus company developed the SRS endoscope, for the non-invasive treatment of gastroesophageal reflux disease, one of the most common chronic diseases in the Western world. The endoscope will replace a significant part of the surgeries currently accepted for the treatment of the disease. In standard surgery, the stomach is entered through several holes, the upper part is taken and wrapped around the esophagus. Medigos performs the same surgery only from the inside, through the body's natural perforations, without full anesthesia and without opening or puncturing the abdominal cavity, and this by creating a special anatomical structure, which manages to prevent the return of stomach fluids to the esophagus.

2 תגובות

  1. The antibody developed by Maimonidex is against a molecule called CD44. This molecule is expressed on the surface of many immune cells and is essential for their migration to different destinations in the body. According to their claim, this antibody is specific to the isoform (that is, a different form of the protein obtained as a result of alternative splicing) expressed on the inflammatory cells in the joints. In this way, migration and normal activity of immune cells will not be affected.

  2. "Radioactive radiation that is not harmful"?
    What is the meaning of this?

    Alpha Beita Gamma - the three radioactive radiations and all of them are harmful. The alpha is short-lived, so it may be possible to mask it with a thin layer of material. This is probably what the poet meant. No, the radiation is not harmful, but if the device is built so that the radiation in it will not reach the tissues and will not cause breaks in the genome.

Leave a Reply

Email will not be published. Required fields are marked *

This site uses Akismat to prevent spam messages. Click here to learn how your response data is processed.